Correlation Between Jasper Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Jasper Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jasper Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jasper Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Jasper Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jasper Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jasper Therapeutics and Ikena Oncology.
Diversification Opportunities for Jasper Therapeutics and Ikena Oncology
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Jasper and Ikena is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Jasper Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jasper Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Jasper Therapeutics i.e., Jasper Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Jasper Therapeutics and Ikena Oncology
Assuming the 90 days horizon Jasper Therapeutics is expected to under-perform the Ikena Oncology. In addition to that, Jasper Therapeutics is 4.77 times more volatile than Ikena Oncology. It trades about -0.01 of its total potential returns per unit of risk. Ikena Oncology is currently generating about -0.01 per unit of volatility. If you would invest 172.00 in Ikena Oncology on August 29, 2024 and sell it today you would lose (1.00) from holding Ikena Oncology or give up 0.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 86.36% |
| Values | Daily Returns |
Jasper Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| Jasper Therapeutics |
| Ikena Oncology |
Jasper Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Jasper Therapeutics and Ikena Oncology
The main advantage of trading using opposite Jasper Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jasper Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Jasper Therapeutics vs. Eliem Therapeutics | Jasper Therapeutics vs. Scpharmaceuticals | Jasper Therapeutics vs. Milestone Pharmaceuticals | Jasper Therapeutics vs. Seres Therapeutics |
| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. Scpharmaceuticals | Ikena Oncology vs. Milestone Pharmaceuticals | Ikena Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |